HAYWARD, Calif., Aug. 31 /PRNewswire-FirstCall/ -- Cholestech
Corporation (Nasdaq: CTEC), a leading manufacturer of point of care testing
devices, today announced that Warren E. Pinckert II, President and CEO, and
Jack Glenn, CFO, will present at the Roth Capital Partners' 2006 New York
Investor Conference on Thursday, September 7, 2006, at 10:00 a.m. Eastern
Time in New York City, New York. The presentation will include an overview
of the company, current products, product pipeline and recent financial
performance; and will be webcast and accessible on Cholestech's website at
http://www.cholestech.com .
About Cholestech
Cholestech is committed to enabling people to lead longer, healthier
and more active lives. Cholestech provides easy to use, accessible
diagnostic tools and information to health care practitioners in over 35
countries around the world. Cholestech offers efficient and economic
diagnostic testing for cholesterol and related lipids, blood glucose and
glycemic control, and liver enzymes at the point of care. Health care
providers can use the CLIA-waived Cholestech LDX(R) and GDX(TM) Systems and
the hs-CRP test, which is cleared by the FDA for use in moderate complexity
labs, to initiate and monitor the progress of patient therapy. By providing
effective disease management solutions, Cholestech's goal is to be a
leading provider of diagnostic tools and information for immediate risk
assessment and therapeutic monitoring of heart disease and diabetes.
Cholestech LDX(R) is a registered trademark and Cholestech GDX(TM) is a
trademark of Cholestech Corporation. All other trademarks mentioned in this
document are the property of their respective owners. For more information
about Cholestech and its products visit us on the web at http://www.cholestech.com
.
SOURCE Cholestech Corporation
 back to top
Related links:
http://www.cholestech.com
CONTACT:
Jack Glenn, Chief Financial Officer of
Cholestech Corporation, +1-510-781-5065, or
jglenn@cholestech.com; or investors, Brendan Lahiff of Financial
Dynamics, +1-415-439-4504, or brendan.lahiff@fd.com, for
Cholestech Corporation
|
